| Literature DB >> 25725608 |
Marta Figueiras1, Lis Coelho2, Kathryn J Wicht3, Sofia A Santos4, João Lavrado1, Jiri Gut5, Philip J Rosenthal5, Fátima Nogueira2, Timothy J Egan3, Rui Moreira1, Alexandra Paulo6.
Abstract
We recently reported that potent N10,O11-bis-alkylamine indolo[3,2-b]quinoline antimalarials act as hemozoin (Hz) growth inhibitors. To improve access and binding to the target we have now designed novel N10,N11-di-alkylamine bioisosteres. 3-Chloro derivatives (10a-f) showed selectivity for malaria parasite compared to human cells, high activity against Plasmodium falciparum chloroquine (CQ)-resistant strain W2 (IC50s between 20 and 158nM), good correlation with β-hematin inhibition and improved vacuolar accumulation ratios, thus suggesting inhibition of Hz growth as one possible mechanism of action for these compounds. Moreover, our studies show that Hz is a valid target for the development of new antimalarials able to overcome CQ resistance.Entities:
Keywords: Hemozoin; Indolo[3,2-b]quinolines; Malaria; Resistance; Vacuolar accumulation
Mesh:
Substances:
Year: 2015 PMID: 25725608 DOI: 10.1016/j.bmc.2015.02.007
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641